Il Terziario.info

news, commenti e approfondimenti sul terziario italiano

Tuesday

Mar 02nd

Text size

Home

FESTA DELLA FOCACCIA A RECCO DOMENICA 24 MAGGIO

FESTA DELLA FOCACCIA A RECCO DOMENICA 24 MAGGIO

Venerdì 22 Maggio 2015 13:53

più letti

English

Move
Close

Main Menu

C&H news

Latest comments

Top Stories in English

B.C. records January’s largest ever total for lives lost due to illicit drugs The BC Coroners Service said an average of 5.3 people died each day in the first month of the year due to the toxic drug supply in the province. Health 39 mins
Novartis : Merck to help make Johnson & Johnson's COVID-19 vaccine -White House official
Secrets of Unopened Letter From Renaissance Europe Revealed – Without Breaking Its Seal or Damaging It
Coronavirus variant 1st found in South Africa discovered in Manitoba
How Microsoft Plans To Give Virtual Reality Apps a Big Boost
Desmond inquiry: psychiatrist says Desmond was eager to improve his life and marriage
N74bn recovered by ex-pension boss Maina was used to finance 2012 Budget, witness tells court
‘Poaching spree’ gets man banned from hunting in 48 states, Colorado officials say
El Salvador's Bukele celebrates major election win SAN SALVADOR (Reuters) - El Salvadoran President Nayib Bukele declared a major victory in legislative elections, citing a projection that his party and allies won more than two-thirds of seats in what would be the biggest majority in the history of the nation's Congress. "Historic! Thank you Salvadoran people. Tha... 1h ago
Maradona's Porsche from 'forgotten' season up for sale 1h ago
White House using Defense Production Act to equip Merck plants for Johnson & Johnson vaccine NEW YORK (Reuters) - The United States is using the Defense Production Act to equip drugmaker Merck & Co's plants to make Johnson & Johnson's just approved COVID-19 vaccine, White House press secretary Jen Psaki said on Tuesday. "As soon as we learned about the fact that Johnson and Johnson was behind in t... 39m ago
U.S. NIH halts trial testing COVID-19 blood plasma (Reuters) - The U.S. National Institutes of Health (NIH) said on Tuesday it had halted a trial testing convalescent blood plasma in treatment of patients with mild to moderate COVID-19 symptoms. The NIH said an independent data monitoring board found that the plasma was unlikely to benefit this group of patients. () (R... 56m ago
EU recovery funds for telcom networks must help competition - Vestager
A year in, coronavirus rages in vaccine-needy West Bank
Tribes, fishermen slam halt to Alaska-Canada water analysis

Malwarebytes for Home | Anti-Malware Premium | Free Trial Download